Showing results (51-60 of 316) with videos related to
Sort By:
Pageof 32
Current Drug Targets|August 9, 2021
Emerging Role of Circular RNAs in Kidney Diseases in NephrologyCong Ma, Junjun Luan, Jeffrey B Kopp, et al.American Journal of Physiology. Renal Physiology|September 20, 2013
TGF-β1 stimulates mitochondrial oxidative phosphorylation and generation of reactive oxygen species in cultured mouse podocytes, mediated in part by the mTOR pathwayYoshifusa Abe, Toru Sakairi, Craig Beeson, et al.Seminars in Nephrology|November 18, 2008
Viruses and kidney disease: beyond HIVMeryl Waldman, Vickie Marshall, Denise Whitby, et al.Seminars in Nephrology|September 3, 2010
MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?Jeffrey B Kopp, Cheryl A Winkler, George W NelsonAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicityMonique E Cho, John K Hurley, Jeffrey B KoppAmerican Journal of Physiology. Renal Physiology|July 30, 2010
Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytesToru Sakairi, Yoshifusa Abe, Parmijit S Jat, et al.Frontiers in Medicine|November 12, 2021
Lessons From APOL1 Animal ModelsTeruhiko Yoshida, Khun Zaw Latt, Jurgen Heymann, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 23, 2018
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKDBarry I Freedman, Sophie Limou, Lijun Ma, et al.Frontiers in Medicine|November 15, 2021
Glomerular Kidney Diseases in the Single-Cell EraKhun Zaw Latt, Jurgen Heymann, Teruhiko Yoshida, et al.Advances in Chronic Kidney Disease|August 30, 2014
APOL1 kidney risk alleles: population genetics and disease associationsSophie Limou, George W Nelson, Jeffrey B Kopp, et al.Pageof 32